Kantum Pharma
Developing groundbreaking therapies and innovative diagnostics to help clinicians prevent and treat acute kidney injury, potentially saving countless lives.
est. 2016
T2 Biosystems
Rapid detection of sepsis-causing pathogens
140 employees · est. 2006 · Lexington, United States
T2 Biosystems is the older company (2016 vs 2006).
Side-by-Side Comparison
| Metric | Kantum Pharma | T2 Biosystems |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2006 older |
| Headquarters | ||
| Headquarters | Not tracked yet | Lexington, United States |
| Employees | ||
| Employees | Not tracked yet | 140 |
| Industry | ||
| Industry | Biopharma, Biotechnology, Health Care | Biotechnology, Health Care |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $3.53M | $316.63M |
| Funding Rounds | ||
| Funding Rounds | 3 | 14 |
| Services | ||
| Services | Not tracked yet | Not tracked yet |
| Target Customers | ||
| Target Customers | Not tracked yet | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Acute Kidney Injury, Therapeutics, Diagnostics, Cardiovascular Interventions, Critical Care, Selective Receptor Antagonist, UDP-G Diagnostic Test, Prophylaxis, Clinical Studies, ICU Settings, Sepsis, Polytrauma, Nephrotoxicity, Early Diagnosis, Patient Selection | Medical Diagnostics, In Vitro Diagnostics, Sepsis, Hemostasis, Bacteria, Lyme Disease, Pathogen Detection, T2MR® Technology, Nanotechnology, Magnetic Resonance Technology, Rapid Diagnostics, FDA-cleared Products, Medical Innovation, Health Technology |
| Website | ||
| Website | kantumpharma.com | t2biosystems.com |
About Kantum Pharma
Kantum Pharma is a biopharmaceutical startup that aims to revolutionize the prevention and treatment of acute kidney injury (AKI). The company's slogan, “Developing groundbreaking therapies and innovative diagnostics to help clinicians prevent and treat acute kidney injury, potentially saving countl...
About T2 Biosystems
T2 Biosystems is dedicated to the rapid detection of sepsis-causing pathogens. The company, established in 2006 and headquartered in the United States, focuses on developing innovative diagnostic products to improve patient health, particularly targeting sepsis, hemostasis, bacteria, and Lyme diseas...
We will tell you when either one moves
BounceWatch watches Kantum Pharma and T2 Biosystems for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Kantum Pharma and T2 Biosystems — by email.
Frequently Asked Questions
Compare Kantum Pharma with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Kantum Pharma on 12 Sep 2024, and T2 Biosystems on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.